Cancer Research Landon Prizes for Basic and Translational Cancer Research  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 57, 1673-1677, May 1, 1997]
© 1997 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wei, Q.
Right arrow Articles by Kyritsis, A. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wei, Q.
Right arrow Articles by Kyritsis, A. P.

Reduced Expression of Mismatch Repair Genes Measured by Multiplex Reverse Transcription-Polymerase Chain Reaction in Human Gliomas1

Qingyi Wei2, Melissa L. Bondy, Li Mao, Yongli Guan, Lie Cheng, Joan Cunningham, Youhong Fan, Janet M. Bruner, W. K. Alfred Yung, Victor A. Levin and Athanassios P. Kyritsis

Departments of Epidemiology [Q. W., M. L. B., Y. G., L. C., J. C.], Thoracic and Head and Neck Medical Oncology [L. M., Y. F.], Pathology [J. M. B.], and Neuro-Oncology [W. K. A. Y., V. A. L., A. P. K.], The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030

Microsatellite instability (MIN) is frequently observed in hereditary nonpolyposis colon cancer and in other sporadic cancers including gliomas. Abnormalities in at least one of five mismatch repair (MMR) genes are implicated in the development of cancers in hereditary nonpolyposis colon cancer and the associated MIN. Using a newly developed multiplex reverse transcription-PCR assay, we evaluated the expression of the five known human MMR genes (hMSH2, hMLH1, hPMS1, hPMS2, and GTBP) in human gliomas by measuring simultaneously the relative levels of the transcripts. The ß-action gene was used as an internal control for RNA degradation and DNA contamination and as a reference for quantifying the levels of their transcripts. Of the 33 gliomas examined, 42% (14) had low expression of hMSH2 (at least 4–5-fold lower than normal mean), 21% (7) had low expression of hMLH1, and 18% (6) had low expression of hPMS1 compared with the expression in the lymphocytes from 13 normal individuals. Furthermore, six of the 33 (18%) tumor samples had decreased expression of more than one MMR gene. Two of these six patients with multiple gene abnormalities had second primary cancers, and an additional patient had multifocal gliomas. Further molecular analysis of available DNA samples indicated that one of five of those tumors with aberrant expression of MMR genes had MIN, as compared with none of five tumors with normal expression. These data suggest that reduced expression of MMR genes is frequent in human gliomas and that aberrant expression of more than one MMR gene may be associated with increased risk of second primary malignancies in glioma patients.

1 This work was supported in part by a grant from the Charlotte Geyer Foundation (to M. L. B.), by NIH Grants CA70242 and CA70334 (to Q. W.), CA 70917 (to M. L. B.) and CA 55261 (to V. A. L.), and by National Cancer Institute Core Grant CA16672 to M. D. Andeson Cancer Center.

2 To whom requests for reprints should be addressed, at Department of Epidemiology, Box 189, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030. Phone: (713) 792-3020; Fax: (713) 792-0807; E-mail: qwei@request.mda.uth.tmc.edu.

Received 12/31/96. Accepted 3/20/97.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
L. Yang, M. J. Clarke, B. L. Carlson, A. C. Mladek, M. A. Schroeder, P. Decker, W. Wu, G. J. Kitange, P. T. Grogan, J. M. Goble, et al.
PTEN Loss Does Not Predict for Response to RAD001 (Everolimus) in a Glioblastoma Orthotopic Xenograft Test Panel
Clin. Cancer Res., June 15, 2008; 14(12): 3993 - 4001.
[Abstract] [Full Text] [PDF]


Home page
Neuro OncolHome page
M. Wrensch, T. Rice, R. Miike, A. McMillan, K. R. Lamborn, K. Aldape, and M. D. Prados
Diagnostic, treatment, and demographic factors influencing survival in a population-based study of adult glioma patients in the San Francisco Bay Area
Neuro-oncol, January 1, 2006; 8(1): 12 - 26.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. Fukushima, Y. Katayama, T. Watanabe, A. Yoshino, A. Ogino, T. Ohta, and C. Komine
Promoter Hypermethylation of Mismatch Repair Gene hMLH1 Predicts the Clinical Response of Malignant Astrocytomas to Nitrosourea
Clin. Cancer Res., February 15, 2005; 11(4): 1539 - 1544.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
K. Nomoto, M. Maekawa, K. Sugano, M. Ushiama, N. Fukayama, S. Fujita, and T. Kakizoe
Methylation Status and Expression of Human Telomerase Reverse Transcriptase mRNA in Relation to Hypermethylation of the p16 gene in Colorectal Cancers as Analyzed by Bisulfite PCR-SSCP
Jpn. J. Clin. Oncol., January 1, 2002; 32(1): 3 - 8.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
T. Hanaoka, Y. Yamano, H. Hashimoto, J. Kagawa, and S. Tsugane
A Preliminary Evaluation of Intra- and Interindividual Variations of hOGG1 Messenger RNA Levels in Peripheral Blood Cells as Determined by a Real-Time Polymerase Chain Reaction Technique
Cancer Epidemiol. Biomarkers Prev., November 1, 2000; 9(11): 1255 - 1258.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
G. Xinarianos, T. Liloglou, W. Prime, P. Maloney, J. Callaghan, P. Fielding, J. R. Gosney, and J. K. Field
hMLH1 and hMSH2 Expression Correlates with Allelic Imbalance on Chromosome 3p in Non-Small Cell Lung Carcinomas
Cancer Res., August 1, 2000; 60(15): 4216 - 4221.
[Abstract] [Full Text]


Home page
JNCI J Natl Cancer InstHome page
I. U. Ali, L. M. Schriml, and M. Dean
Mutational Spectra of PTEN/MMAC1 Gene: a Tumor Suppressor With Lipid Phosphatase Activity
J Natl Cancer Inst, November 17, 1999; 91(22): 1922 - 1932.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
L. Cheng, Y. Guan, L. Li, R. J. Legerski, J. Einspahr, J. Bangert, D. S. Alberts, and Q. Wei
Expression in Normal Human Tissues of Five Nucleotide Excision Repair Genes Measured Simultaneously by Multiplex Reverse Transcription-Polymerase Chain Reaction
Cancer Epidemiol. Biomarkers Prev., September 1, 1999; 8(9): 801 - 807.
[Abstract] [Full Text]


Home page
Arch Otolaryngol Head Neck SurgHome page
E. M. Sturgis, G. L. Clayman, Y. Guan, Z. Guo, and Q. Wei
DNA Repair in Lymphoblastoid Cell Lines From Patients With Head and Neck Cancer
Arch Otolaryngol Head Neck Surg, February 1, 1999; 125(2): 185 - 190.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. K. Chang, L. Ricciardiello, A. Goel, C. L. Chang, and C. R. Boland
Steady-state Regulation of the Human DNA Mismatch Repair System
J. Biol. Chem., June 9, 2000; 275(24): 18424 - 18431.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1997 by the American Association for Cancer Research.